Vascular access type and changes in inflammatory markers in incident dialysis patients: A pilot study

Journal of Vascular Access

Volumn 10, Issue 3, 2009, Pages 174-179

  Sachdeva, Mala ^a   Kovalchuk, Oleksander ^a   Bitzer, Markus ^a   Mokrzycki, Michele Helene ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

C reactive protein; Chronic kidney disease; Hemodialysis; Inflammation; Interleukin 6; Vascular access

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; INSULIN; INTERLEUKIN 6; STATIN; VITAMIN D; AUTACOID; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTERY CATHETER; ARTICLE; BACTEREMIA; BLOOD SAMPLING; CATHETER THROMBOSIS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY ARTERIOVENOUS FISTULA; KIDNEY GRAFT; MALE; PERIPHERAL VASCULAR DISEASE; PILOT STUDY; VASCULAR ACCESS; ARTERIOVENOUS SHUNT; BLOOD; BLOOD VESSEL TRANSPLANTATION; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; INCIDENCE; INDWELLING CATHETER; INFLAMMATION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; TIME;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; BIOLOGICAL MARKERS; BLOOD VESSEL PROSTHESIS IMPLANTATION; C-REACTIVE PROTEIN; CATHETERS, INDWELLING; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INCIDENCE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS;

EID: 70350702564     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.1177/112972980901000307     Document Type: Article

References (22)

1. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-911.
2. Zimmerman J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-58.
3. Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortality in hemodialysis patients. Nephrol Dial Transplant 2002; 17 (suppl): S29-32.
4. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956-60.
5. Pasceri V, Wu HD, Willerson JT, Yeh ETH. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-activators. Circulation 2000; 101: 235-8.
6. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992; 4: 361-8.
7. Korevaar JC, Van Manen JG, Dekker FW, et al. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. J Am Soc Nephrol 2004; 15: 2916-22.
8. Memoli B, Libetta C, Rampino R, et al. Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. Nephol Dial Transplant 1991; 2 (suppl): S96-8.
9. Honkanen E, Gronhagen-Riska C, Teppo AM, et al. Acute phase proteins during haemodialysis: correlations with serum interleukin-1 beta levels and different dialysis membranes. Nephron 1991; 57: 283-7.
10. Schindler R, Boenisch O, Fischer C, Frei U. Effect of the haemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 2000; 53: 452-9.
11. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 2000; 15: 1207-11.
12. Nassar GM, Fishbane S, Ayus JC. Occult infection of old non-functioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients. Kidney Int 2002; 61 (suppl): S49-54.
13. Caglar k, Peng Y, Pupim LB, et al. Inflammatory signals associated with hemodialysis. Kidney Int 2002; 62: 1408-16.
14. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 2000; 58: 346-52.
15. Visser R, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial 1999; 15: 222-5.
16. Khan IH, Catto GR, Edward N, Fleming LW, Henderson IS, MacLeod AM. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-8.
17. Smirnakis K, Wolf M, Thadhani R. Vascular access, inflammation and 90-day mortality in incident hemodialysis patients. J Am Soc Nephrol 2005; 16: 452A.
18. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15: 477-86.
19. Harbord N, Kuntsevich V, Kotanko P, et al. Altered cytokine/chemokine (CK/CC) profiles and CRP in hemodialysis subjects with hemodialysis catheters (HDC) and fistulae (F).J Am Soc Nephrol 2007; 18: 278A.
20. Movilli E, Brunori G, Camerini C, et al. The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif 2006; 24: 387-93.
21. Hung AM, Ikizler TA. Hemodialysis central venous catheters as a source of inflammation and its implications. Semin Dial 2008; 21: 401-4.
22. Hung AM, Pupim LB, Yu C, et al. Determinants of C-reactive protein in chronic hemodialysis patients. Hemodial Int 2008; 12: 236-43.